NCT04335344已完成不适用
Evaluation of Plasma and Salivary suPAR in Periodontitis and CVD Patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 326
- 试验地点
- 1
- 主要终点
- Clinical attachment level
研究概览
简要总结
soluble urokinase-type plasminogen activator receptor (suPAR) plays a key role in endothelial function and may be a link for the known interaction of periodontitis and cardiovascular disease (CVD). The investigators compared the impact of gingival health, periodontitis (CP), CHD or of both diseases (CP+CHD) on saliva and serum suPAR levels.
详细描述
The aim of this study was to evaluate a possible association between both saliva and serum suPAR levels in patients with CP and with CVD and if the serum suPAR levels are mediated by serum CRP.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 40 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Presence of at least 15 teeth
- •CP with a minimum of 40% of sites with a clinical attachment level (CAL) ≥2mm and probing depth (PD) ≥4mm;
- •Presence of at least ≥2 mm of crestal alveolar bone loss verified on digital periapical radiographs
- •Presence of ≥40% sites with bleeding on probing (BOP)
排除标准
- •Intake of contraceptives
- •Intake of immunosuppressive or anti-inflammatory drugs throughout the last three months prior to the study
- •Status of pregnancy or lactation
- •Previous history of excessive drinking
- •Allergy to local anaesthetic
- •Intake of drugs that may potentially determine gingival hyperplasia such as Hydantoin, Nifedipine, Cyclosporin A or similar drugs.
结局指标
主要结局
Clinical attachment level
时间窗: 1-year
evaluation of changes in clinical attachment level
次要结局
未报告次要终点
研究者
Gaetano Isola, DDS, PhD
Researcher
University of Messina
研究点 (1)
Loading locations...
相似试验
已完成
不适用
SuPAR in Adult Patients With Covid-19Covid19NCT04590794University of Thessaly767
已完成
不适用
suPAR is a Potential Biomarker of in Chronic Periodontitis Through the Impact of Post-radiotherapy on HNCs PatientsHead and Neck CancerChronic PeriodontitisComplications RadiotherapyNCT06481059Al-Maarif University College150
已完成
不适用
Estimation of (suPAR) in Chronic Periodontitis With Post-radiotherapy on HNCs PatientsHead and Neck CancerChronic PeriodontitisRadiotherapy Side EffectNCT06529588Al-Maarif University College150
已完成
不适用
Prognostic Value of Soluble Urokinase Plasminogen Activation Receptor (SUPAR) to Rule Out Complications in Patients Admitted in Emergency Department for Acute Abdominal Pain.Soluble Urokinase Plasminogen Activation ReceptorAbdominal PainEmergency DepartmentMortalityNCT05580016Poitiers University Hospital200
已完成
不适用
Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart DiseaseSevere Aortic Stenosis or Severe Aortic RegurgitationNCT04571372Yonsei University222